Literature DB >> 26243815

Misplaced advocacy: What does better hepatitis C treatment really mean?

Mark Tyndall1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26243815      PMCID： PMC4610829          DOI： 10.1503/cmaj.150612

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.

Authors:  Will Small; S Kain; Nancy Laliberte; Martin T Schechter; Michael V O'Shaughnessy; Patricia M Spittal
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

2.  Deadly disregard: government refusal to implement evidence-based measures to prevent HIV and hepatitis C virus infections in prisons.

Authors:  Richard Elliott
Journal:  CMAJ       Date:  2007-07-31       Impact factor: 8.262

3.  Seroprevalence and correlates of HIV and HCV among injecting drug users in Edmonton, Alberta.

Authors:  Sabrina S Plitt; Jennifer Gratrix; Sharyn Hewitt; Patsy Conroy; Tracy Parnell; Beverly Lucki; Vicki Pilling; Barbara Anderson; Yogesh Choudri; Chris P Archibald; Ameeta E Singh
Journal:  Can J Public Health       Date:  2010 Jan-Feb

4.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

5.  Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada.

Authors:  Gregory D Deans; Jesse D Raffa; Calvin Lai; Benedikt Fischer; Mel Krajden; Janaki Amin; Scott R Walter; Gregory J Dore; Jason Grebely; Mark W Tyndall
Journal:  CMAJ Open       Date:  2013-05-23

6.  Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth.

Authors:  Scott E Hadland; Kora DeBeck; Thomas Kerr; Cindy Feng; Julio S Montaner; Evan Wood
Journal:  BMJ Open       Date:  2014-07-21       Impact factor: 2.692
  6 in total
  2 in total

1.  Well-placed advocacy.

Authors:  Bonnie R Larson
Journal:  CMAJ       Date:  2016-10-18       Impact factor: 8.262

2.  Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.

Authors:  Nadine Kronfli; Sahir R Bhatnagar; Mark W Hull; Erica E M Moodie; Joseph Cox; Sharon Walmsley; John Gill; Curtis Cooper; Valérie Martel-Laferrière; Neora Pick; Marina B Klein
Journal:  AIDS       Date:  2019-05-01       Impact factor: 4.177
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.